Episodes - The Bloodline with Blood Cancer United Podcast

Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses current treatments for chronic lymphocytic leukemia (CLL) and the exciting possibilities for the future using immunotherapies.

Dr. Davids shares how the goal of treatment is long term remission and quality of life. Since 2010, BTK Inhibitors, CAR T-cell therapy and other treatments have come on the market and have increased the possibilities for patients to live a long life with CLL.

Mentioned on this episode: 

• Chronic Lymphocyctic Leukemia (CLL)
• How CAR T Cell Therapy Gives Hope to Cancer Patients Podcast Episode
• CURE Magazine Article on CAR T and Young CLL Patients
• American Journal of Managed Care – CAR T cells persist
• Minimal/Measurable Residual Disease (MRD) Fact Sheet
• CAR T-cell Therapy
• CAR T-Cell Therapy Webinar
• How CAR T-Cell Therapy Works In Augmented Reality
• Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Autologous Stem Cell Transplant
• LLS COVID-19 Resources
• Clinical Trial Support Center
• The Bloodline Subscriber Lounge

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by BeiGene USA, Inc.; Bristol Myers Squibb; Genentech, Inc. & Biogen; Loxo Oncology at Lilly and Pharmacyclics, An AbbVie Company & Janssen Biotech, and Thomas D. Oxley Fund for CLL Patient Education and Support.

The post Achieving Long-term Remission with Chronic Lymphocytic Leukemia (CLL) first appeared on The Bloodline with LLS.

Please join us for our second live episode from CancerCon®, a young adult cancer conference presented by Stupid Cancer®. In this episode, we’ll be speaking with experts who discussed survivorship planning, imposter syndrome, and developing a growth mindset.

Cancer patients and survivors of all ages, whether newly diagnosed, in treatment or post-treatment, can benefit from hearing from these experts.

Be sure to tune into the previous episode from CancerCon, where we hear from young adult cancer patients and survivors on what the word, “survivorship” means to them and how that meaning may have changed throughout their cancer experience.

Mentioned on this episode: 

• Survivorship Definition – National Cancer Institute
• Survivorship Workbook
• Young Adult Online Chat
• Young Adult Resources
• Stupid Cancer®
• National Cancer Institute Cancer Centers
• Grow Into Greatness
• First Descents®

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy

The post LIVE! at CancerCon: Navigating Young Adult Cancer first appeared on The Bloodline with LLS.

Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®. In this episode, we’ll be speaking with patients and survivors about what the word, “survivorship” means to them.

We found the responses to this question can vary from patient to patient and even change once treatment ends. We hope that through their words, listeners will find a sense of connection and evaluate their own meaning of survivorship.

Be sure to stay tuned for the next episode from CancerCon, where we will be hearing from experts who presented on various aspects of survivorship, such as the growth mindset, creating a survivorship plan, and imposter syndrome.

Mentioned on this episode: 

• Survivorship Definition – National Cancer Institute
• Survivorship Workbook
• Young Adult Online Chat
• Stupid Cancer
• LLS Dare to Dream
• Stem Cell Transplant
• Be The Match
• Armenian Bone Marrow Registry

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy

The post LIVE! At CancerCon: A Journey Through Survivorship first appeared on The Bloodline with LLS.

Please join us as we speak to Dr. Shernan Holtan and guest co-host from LLS, Christina Neilsen. In this episode, Dr. Holtan discusses stem cell transplants; how they work, the different types of transplants, and the side effects, including graft-vs-host disease (GVHD).

Dr. Holtan shares exciting new research on reducing GVHD and provides blood cancer patients with hope as transplantations continue to improve and bring about potential cures.

Mentioned on this episode: 

• Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Autologous Stem Cell Transplant
• Graft-verses-Host Disease Fact Sheet
• CAR T-cell Therapy
• Clinical Trial Support Center
• Hope Lodge
• Posttransplant Cyclophosphamide
• Be The Match

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

The post Let’s Talk About Stem Cell Transplantation: Benefits and Side Effects first appeared on The Bloodline with LLS.

Please join us as we speak to Dr. John Leonard of Weill Cornell Medicine. In this episode, Dr. Leonard discusses the broad array of immunotherapy treatments, in which a patient’s own immune system is stimulated to fight cancer cells.

From CAR T-cell therapy to monoclonal antibodies to new bispecific therapies, Dr. Leonard shares how these immunotherapies are changing the landscape of cancer treatment and giving hope to more blood cancer patients.

Mentioned on this episode: 

• Immunotherapies for Blood Cancer
• CAR T-cell Therapy
• CAR T-Cell Therapy Webinar
• How CAR T-Cell Therapy Works In Augmented Reality
• Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Autologous Stem Cell Transplant
• Diagnosed with Diffuse Large B-Cell Lymphoma. Now What? Podcast episode
• Clinical Trial Support Center

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

The post Immune System To The Rescue: Immunotherapies In Blood Cancer first appeared on The Bloodline with LLS.

Únase a nosotros mientras hablamos con Ana Zermeño y Ana Victoria Portillo sobre asistencia financiera y recursos para pacientes que enfrentan un diagnóstico de cáncer de la sangre. Ana Zermeño es trabajadora social del Centro Médico de la Universidad de California en San Francisco. Ana Victoria Portillo, también trabajadora social, es Especialista en Información en La Sociedad de Lucha contra la Leucemia y el Linfoma (LLS, por sus siglas en inglés). Ambos ayudan a los pacientes y sus familias a navegar por sus finanzas, así como a encontrar información y apoyo. En este episodio se analizan los recursos financieros.

Enlaces:

• Programas de asistencia económica al paciente
• Especialista en Información de LLS
• LLS.org/Espanol
• Ayuda con los asuntos financieros / Help With Finances
• El cáncer y tus finanzas
• Programas sociales del Gobierno

Por favor, envíenos sus comentarios sobre este episodio. Si desea asistencia financiera personalizada, proporciónenos su nombre, dirección de correo electrónico y/o número de teléfono para que un Especialista en Información se comunique con usted.

The post En Español: Asistencia Financiera Después de su Diagnóstico first appeared on The Bloodline with LLS.

Please join us as we speak to Dr. Daniel Pollyea from the University of Colorado School of Medicine.  In this episode, Dr. Pollyea discusses the group of diseases that make up Myelodysplastic Syndromes (MDS) and how their variability leads to different treatments and prognoses, from active monitoring to chemotherapy and/or stem cell transplantation.  He shares his excitement about new treatment advances and is looking forward to an era of innovative targeted treatments for MDS.

Mentioned on this episode: 

• Myelodysplastic Syndromes (MDS)
• Myelodysplastic Syndromes (MDS) Booklets
• Acute Myeloid Leukemia (AML)
• Stem Cell Transplant
• IPSS-R Scoring System
• IPSS-M Scoring System
• Clinical Trial Support Center

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by Taiho Oncology.

The post Myelodysplastic Syndromes (MDS): A Group of Diseases first appeared on The Bloodline with LLS.

Please join us as we speak to Howard Willens, a chronic myelomonocytic leukemia (CMML) patient. In this episode, Howard shares how he was diagnosed with this rare blood cancer. He shares how patient support groups have assisted him, and how he no longer feels alone. His story encourages CMML patients to focus on stability and the present, while living their lives to the fullest.

Mentioned on this episode: 

• Chronic Myelomonocytic Leukemia (CMML)
• CMML Fact Sheet
• Stem Cell Transplant
• Myelodysplastic Syndromes (MDS)
• Myeloproliferative Neoplasms (MPNs)
• Mental Health Resources
• LLS Community 
• CMML Friends on Facebook

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by Taiho Oncology.

The post Support and Stability: Living with CMML first appeared on The Bloodline with LLS.

Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part Two of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the development and utilization of CAR T-cell therapy for MCL. Approved in July of 2020 for relapsed or refractory MCL, CAR T-cell therapy has shown incredible promise and is already giving hope to patients and doctors as a potential cure.

Be sure to tune into Part 1, where Dr. Lampson discussed the current treatments and latest advances for MCL.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by Bristol Myers Squibb; CRISPR Therapeutics; Janssen Oncology & Legend Biotech; KITE, a Gilead Company and Novartis Pharmaceuticals Corporation.

The post Mantle Cell Lymphoma (MCL) Part Two: CAR T-Cell Therapy first appeared on The Bloodline with LLS.

Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part One of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the latest treatment advances for MCL. With more treatments available than just a few years ago, Dr. Lampson shares how his conversations with his patients have changed, providing more hope after a diagnosis of MCL.

Be sure to tune into Part 2 launching on May 23, 2022, where Dr. Lampson will focus on the exciting possibilities of CAR T-cell therapy for MCL.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by Eli Lilly & Company.

The post Mantle Cell Lymphoma (MCL) Part One: Treatment Advances first appeared on The Bloodline with LLS.